Tag Archives: Interventional Cardiology

Most read scientific articles of may in interventional cardiology

The Most Read Scientific Articles of May in Interventional Cardiology

The Most Read Scientific Articles of May in Interventional Cardiology

01- Management of Infarction During the COVID-19 Pandemic Patients with cardiovascular disease infected with COVID-19 are at a particular risk for morbidity and mortality. In any case, it should be noted that most patients requiring cardiovascular care due to ischemic heart disease, peripheral vascular disease, or structural heart disease are not infected. Read more HERE

The most read scientific articles in april

The most read scientific articles on interventional cardiology in april

01- ECS Guidelines for COVID-19 Management One of the first statements in this document points out these are not “regular guidelines” developed after thorough analysis of all the available evidence published since the last update. Instead, they are meant to provide temporary basic management pointers on how to handle different scenarios of cardiac patients in the

implante de la valvula aortica transcateter

TAVR Reaches Low-Risk Patients with Bicuspid Valves

Transcatheter aortic valve replacement (TAVR) seems to be safe in low-risk patients with bicuspid aortic valve stenosis. Their hospital length of stay was very short, with zero mortality, and zero disabling stroke. Subclinical leaflet thrombosis and device durability are still unknown. The United States Food and Drug Administration (FDA) approved TAVR for low-risk patients. However,

Agenda SOLACI 2020

2020 SOLACI Calendar of Events | A Year Full of Extraordinary Interventional Cardiology Events

SOLACI’s commitment to the development of interventional cardiology in Latin America doubles down in 2020. Our institution is fostering a variety of events, programs, and activities to continue boosting our specialty in our region, a tradition we have never ceased to honor in the past 26 years. From February 28th to March 2nd, 2021, Hilton Buenos

Become a SOLACI Member

Be part of SOLACI! Become part of a medical community composed by over 2500 specialists in interventional cardiology (and other specialties) from Latin America. Joining is free! Everyone can join SOLACI, regardless of their profession. According to your specialty, you will become a Full Member (if you are an interventional cardiologist) or an Associate Member

17th SOVECI Congress

The 17th Annual Meeting of the Venezuelan Society of Interventional Cardiology is Coming

On Saturday December 14, 2019, the 17th Meeting of the Venezuelan Society of Interventional Cardiology (SOVECI) will be held at Caracas Clinics Hospital’s Auditorium. National and international specialists will be attending and will be addressing several topics of interest in the field of interventional cardiology. There will also be live and edited cases.  For SOLACI it

mas-leido-noviembre-eng

The Most Read Articles of November at Solaci.org

1- AHA 2019 | ISCHEMIA: The Invasive Approach (PCI or Surgery) Results Similar to Optimal Medical Treatment After a several year follow up, the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) has shown that an invasive approach in addition to optimal medical treatment (OMT) does not offer benefits when it

I CURSO REGIONAL DE INTERVENCIONISMO PARA EL CARDIOLOGO CLINICO

Regional Course of Interventionism for the Clinical Cardiologist | with SOLACI’s Support

On November 30, 2019, the “I Regional Course of Interventionism for the Clinical Cardiologist” will take place in Chiclayo, Peru. The event will be held in the Muchick Room at Costa del Sol Hotel, organized by the Peruvian Society of Hemodynamics and Endovascular Interventionism (SOPHIE) with the support of SOLACI. The activity will be oriented to

The Most Read Scientific Articles in Interventional Cardiology of October

The Most Read Scientific Articles of October in Interventional Cardiology

1- Incidence and Prognosis of Heart Valve Embolization The incidence of peri-procedural transcatheter heart valve embolization and migration (TVEM) is as low as 1%. However, it is associated with increased morbidity and mortality. Read more HERE 2- 1000 MitraClips: Results from the World’s Most Experienced Site In September 2008, interventional physicians at the Heart and

Top